Journal of Clinical Endocrinology & Metabolism, Vol 80, 1888-1893, Copyright © 1995 by Endocrine Society

ARTICLES

Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia

SW Walsh and Y Wang
Department of Obstetrics and Gynecology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0034, USA.

Placentas obtained from women with preeclampsia produce more lipid peroxides and more thromboxane, but less prostacyclin, than normal. The tissue compartments within the placenta that are responsible for this are not known. The placenta is a heterogeneous tissue compartmentalized into trophoblast cells and villous core tissue that is comprised of stromal and vascular tissue. In this study we determined the placental compartments responsible for increased production of lipid peroxides and thromboxane in preeclampsia. Placentas were obtained from six normally pregnant women and seven women with preeclampsia. Trophoblast cells and villous core tissues were isolated and incubated in Dulbecco's Modified Eagle's Medium for 48 h. Samples were collected at 0, 2, 6, 16, 28, and 48 h of incubation and analyzed spectrophotometrically for lipid peroxides by a peroxide equivalent assay and for thromboxane and prostacyclin by RIA of their stable metabolites, thromboxane-B2 and 6-keto-prostaglandin-F1 alpha. Trophoblast cells isolated from preeclamptic placentas produced significantly more lipid peroxides (1972 +/- 502 vs. 1102 +/- 335 pmol/micrograms protein after 48 h of incubation), more thromboxane (328 +/- 57 vs. 153 +/- 53 pg/microgram at 48 h), and more prostacyclin (50 +/- 11 vs. 13 +/- 3 pg/microgram at 48 h, respectively) than trophoblast cells isolated from normal placentas. Villous core tissue isolated from preeclamptic placentas produced significantly more lipid peroxides (455 +/- 107 vs. 241 +/- 34 pmol/microgram) and more thromboxane (148 +/- 51 vs. 76 +/- 14 pg/microgram) than normal villous core tissue, but there was no difference in prostacyclin production (36 +/- 11 vs. 40 +/- 9 pg/microgram). Because of the increase in thromboxane production, the ratio of thromboxane to prostacyclin was higher in preeclamptic than normal villous core tissue (6.29 vs. 2.17). Comparison of production by different compartments within the placenta demonstrated that lipid peroxides and thromboxane were primarily produced by the trophoblast cells and stromal tissue, whereas prostacyclin was primarily produced by the vascular tissue. We conclude that increased placental production of lipid peroxides and thromboxane in preeclampsia originates from both the trophoblast cell and the villous core compartments. As the placenta secretes lipid peroxides, the trophoblast cells could be a source of increased lipid peroxides in the maternal circulation of women with preeclampsia. The increased ratio of thromboxane to prostacyclin in the villous core could be responsible for increased placental vasoconstriction.

This article has been cited by other articles:

				Y. Gu, D. F. Lewis, and Y. Wang Placental Productions and Expressions of Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1, and Placental Growth Factor in Normal and Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 260 - 266. [Abstract] [Full Text] [PDF]

				E. Jauniaux, L. Poston, and G. J. Burton Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution Hum. Reprod. Update, November 1, 2006; 12(6): 747 - 755. [Abstract] [Full Text] [PDF]

				M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839. [Abstract] [Full Text] [PDF]

				F. Miceli, A. Tropea, F. Minici, M. Orlando, G. Lamanna, M. F. Gangale, B. Panetta, F. Tiberi, S. Vaccari, R. Canipari, et al. Effects of Insulin-Like Growth Factor I and II on Prostaglandin Synthesis and Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 372 - 378. [Abstract] [Full Text] [PDF]

				J.-Y. Chung, Y. Song, Y. Wang, R. R. Magness, and J. Zheng Differential Expression of Vascular Endothelial Growth Factor (VEGF), Endocrine Gland Derived-VEGF, and VEGF Receptors in Human Placentas from Normal and Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2484 - 2490. [Abstract] [Full Text] [PDF]

				H. Li, Y. Gu, Y. Zhang, M. J. Lucas, and Y. Wang High Glucose Levels Down-Regulate Glucose Transporter Expression That Correlates With Increased Oxidative Stress in Placental Trophoblast Cells IN Vitro Reproductive Sciences, February 1, 2004; 11(2): 75 - 81. [Abstract] [PDF]

				K. Takanashi, T. Honma, T. Kashiwagi, H. Honjo, and I. Yoshizawa Detection and Measurement of Urinary 2-Hydroxyestradiol 17-Sulfate, a Potential Placental Antioxidant during Pregnancy Clin. Chem., March 1, 2000; 46(3): 373 - 378. [Abstract] [Full Text] [PDF]

				C. A. Hubel Oxidative Stress in the Pathogenesis of Preeclampsia Experimental Biology and Medicine, December 1, 1999; 222(3): 222 - 235. [Abstract] [Full Text]

				S. W. Walsh, Y. Wang, and A. Killian AA-2414, an Antioxidant and Thromboxane Receptor Blocker, Completely Inhibits Peroxide-Induced Vasoconstriction in the Human Placenta J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 220 - 226. [Abstract] [Full Text]

				T. Kriston, R. C. Venuto, C. Baylis, and G. Losonczy Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R831 - R837. [Abstract] [Full Text] [PDF]

				F. V Velzing-Aarts, F. R. van der Klis, F. P. van der Dijs, and F. A. Muskiet Umbilical vessels of preeclamptic women have low contents of both n-3 and n-6 long-chain polyunsaturated fatty acids Am. J. Clinical Nutrition, February 1, 1999; 69(2): 293 - 298. [Abstract] [Full Text] [PDF]

				M. D. Rosenthal, E. D. Albrecht, and G. J. Pepe Developmental Maturation of Baboon Placental Trophoblast: Expression of Messenger Ribonucleic Acid and Protein Levels of Cytosolic and Secretory Phospholipases A2 J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2861 - 2867. [Abstract] [Full Text]

				J.-L. Vigne, J. T. Murai, B. W. Arbogast, W. Jia, S. J. Fisher, and R. N. Taylor Elevated Nonesterified Fatty Acid Concentrations in Severe Preeclampsia Shift the Isoelectric Characteristics of Plasma Albumin J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3786 - 3792. [Abstract] [Full Text] [PDF]

				A. P. Cockell and L. Poston Flow-Mediated Vasodilatation Is Enhanced in Normal Pregnancy but Reduced in Preeclampsia Hypertension, August 1, 1997; 30(2): 247 - 251. [Abstract] [Full Text]

				E. Y. Anteby, R. D. Johnson, X. Huang, D. M. Nelson, and Y. Sadovsky Transcriptional Regulation of Prostaglandin-H Synthase-2 Gene in Human Trophoblasts J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2289 - 2293. [Abstract] [Full Text] [PDF]

				S. M. Cueto, A. D. Romney, Y. Wang, and S. W. Walsh {beta}-Carotene Attenuates Peroxide-Induced Vasoconstriction in the Human Placenta Reproductive Sciences, March 1, 1997; 4(2): 64 - 71. [Abstract] [PDF]

				Y. Wang and S. W. Walsh Antioxidant Activities and mRNA Expression of Superoxide Dismutase, Catalase, and Glutathione Peroxidase in Normal and Preeclamptic Placentas Reproductive Sciences, July 1, 1996; 3(4): 179 - 184. [Abstract] [PDF]